| |
|
|
|
Oxford Global Conferences, Berlin, Germany
08th and 09th June 2015
Oxford Global Conferences are pleased to announce the 3rd Annual Discovery Chemistry & Drug Design Congres with our co-located 16th Annual Drug Discovery Summit 2015, taking place at the Hotel Palace Berlin on the 8-9 June 2015. This two day congress has been developed to offer discovery chemistry leaders an executive platform for networking and discussion. 250 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. 20 presentations and case studies will focus on the key issues in discovery chemistry and drug design.
2 Interactive Streams:
- Discovery Chemistry: Latest Case Studies
- Drug Design: Novel Approaches
The congress is part of the 16th Annual Drug Discovery Leaders Summit – Europe’s premier networking and discussion forum for pharmaceutical leaders.
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global Conferences |
|
|
Invited Speakers:
|
|
- Stevan Djuric, Senior Director Medicinal Chemistry Technologies, AbbVie
- Ingo Mügge, Senior Research Fellow, Boehringer Ingelheim
- Matthias Frech, Director Molecular Interactions & Biophysics, Merck
- Jutta Heim, CEO, Evolva
- Rod Hubbard, Senior Fellow, Vernalis and Professor, York University
- arren Jhoti, President & CEO, Astex Pharmaceuticals
- ain Simpson, Team Leader, Medicinal Chemistry, AstraZeneca
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
For further any information, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or +44(0)3865 248 455
|
|
|
E-mail:
|
|
g.alonso@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|